Fort Lauderdale, Florida
Exosome supply and 503A pharmacy access for Fort Lauderdale practices
ExaVeyra supplies research-use exosome material to licensed practices in Fort Lauderdale from its base in Miami Beach, and because Florida is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice in Broward County can source, how cold-chain material arrives, and where the Florida law questions are answered.
It speaks to the Broward County practice, names no condition or use, and leaves delegation and statute to the Florida sourcing guide.
What a Fort Lauderdale practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Florida, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Fort Lauderdale
Fort Lauderdale is the seat of Broward County, and the clinical centre of the county sits close to its downtown. Broward Health Medical Center on South Andrews Avenue is the flagship of the North Broward Hospital District, one of the larger public hospital systems in the country, and Holy Cross Health on North Federal Highway, a member of Trinity Health, anchors the north side of the city. Cleveland Clinic Weston Hospital serves the western suburbs, Memorial Regional Hospital in Hollywood anchors the south of the county, and Nova Southeastern University in Davie brings two medical colleges and a health professions division to the middle of it. Private practice follows those anchors, with medical office buildings ringing each campus and specialist groups in the office towers along East Broward Boulevard and Las Olas Boulevard. The Broward Health system also runs Broward Health North in Deerfield Beach, Broward Health Imperial Point and Broward Health Coral Springs, so specialist referral traffic moves along the whole county rather than converging on downtown alone.
Dermatology, plastic surgery, aesthetic and med spa practices cluster along Las Olas Boulevard and the Federal Highway corridor between downtown and the Holy Cross campus, and the Cypress Creek office district at the Interstate 95 interchange carries a second concentration, with a multi-tenant medical pavilion built around an ambulatory surgery centre. Concierge and hormone-optimization practices are spread across Wilton Manors, the Galleria district on East Sunrise Boulevard, Plantation and Weston, and the western suburbs have grown their own aesthetic and longevity segments around the Cleveland Clinic campus. Practices here range from solo physician offices to multi-site groups with locations in Palm Beach and Miami-Dade counties, and the patient base is more year-round than in Palm Beach, with a seasonal lift from late autumn through the spring. Port Everglades, the cruise terminal and the marine industry along the New River give the city a hospitality and yachting workforce that keeps the downtown practices busy through the summer months, after the seasonal residents have gone.
A delivery address in Fort Lauderdale takes one of three shapes. Downtown, it is a suite in an office tower on Las Olas or Broward Boulevard with a loading dock, a lobby desk and a security sign-in that a carrier has to clear before reaching the floor. Around the hospital campuses it is a suite in a low-rise medical office building with a shared entrance and a front desk that closes for lunch. On the barrier island and the Las Olas Isles it is an address reached over one of the bascule bridges across the Intracoastal Waterway, and a bridge opening for a yacht can hold a vehicle for several minutes, which matters only when a package is timed to a narrow receiving window. Wilton Manors and Oakland Park sit between the two hospital districts, and their offices are mostly converted storefronts on Wilton Drive and North Andrews Avenue, each with its own door on the street.
Broward County is served by the carrier lane from Miami Beach rather than by local courier, and Fort Lauderdale-Hollywood International Airport is the carrier air gateway for the county, though material from Miami Beach travels by ground. The Fort Lauderdale International Boat Show occupies the Broward County Convention Center, Bahia Mar, the Las Olas Marina, the Seventeenth Street yacht basin and Pier Sixty-Six at the end of October and into the first days of November, and road closures around the Seventeenth Street Causeway and the beach slow access to island addresses that week. Spring break brings the same congestion to the beach in March, and from June through November a named storm can suspend carrier service across South Florida, so dispatch is checked against the forecast during those months. Interstate 95, Florida's Turnpike and Interstate 595 are the ground routes into the county from Miami-Dade, and a weekday morning dispatch from Miami Beach keeps the Broward leg of the lane short, with the vehicle on the road before the afternoon congestion builds on both interstates.
The hair and scalp literature, for Fort Lauderdale practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Fort Lauderdale practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription for a Broward prescriber.
Broward groups with more than one site, in Fort Lauderdale, Plantation and Weston for instance, tend to read that as an account question: each delivery address is listed on the practice account so a lot traces to the site that received it, while each prescription carries its own prescriber and its own patient regardless of which site the patient attends. The Florida Board of Medicine and the Florida Board of Nursing are the bodies that answer delegation questions, which matters in a county where nurse practitioners and physician assistants lead a large share of the aesthetic practices, and the Florida sourcing guide sets those answers out. A practice that also lists a Miami-Dade site on the same account is inside the local courier range for that site and on the carrier lane for its Broward site, and the account notes the difference so that neither desk expects the other's handover.
How material reaches Fort Lauderdale
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Florida practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Florida destinations sit on the shortest lane ExaVeyra runs, and cold-chain shipping is free to Florida destinations from 6 units against 15 units nationwide; the threshold is applied by the cart rather than quoted case by case.
Florida law is a separate question, answered in the state guide
What a Florida practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Florida sourcing guide rather than repeated here. Nothing about the city changes any of it.
Fort Lauderdale sourcing questions
- How does research-use exosome material reach a Fort Lauderdale address?
- It leaves the Miami Beach facility under validated temperature monitoring and travels the Florida lane by carrier from Miami Beach to the address on file, whether a downtown tower, a suite near a hospital campus or an island address over a bridge. Broward County is outside the local courier range, so the Florida delivery terms apply, as do the receiving checks on the cold-chain page.
- Can a Fort Lauderdale practice source both exosome material and compounded preparations?
- Yes. Florida is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber in Fort Lauderdale can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to any licensed practice. They run under separate regimes and never share a shipment or a stocking calendar.
- Are Weston, Plantation, Hollywood and Pompano Beach served the same way as downtown Fort Lauderdale?
- Yes. Each is a Broward County address on the same Florida lane, and a group with a downtown office and a second site in Weston or Hollywood lists both delivery addresses on the practice account so every lot traces to the site that received it. The local difference is access: a suburban office park has a door a carrier reaches directly, while an island suite needs the entrance on file.
Sources
- Florida Board of Medicine (accessed 17 September 2026)
- Florida Board of Pharmacy (accessed 17 September 2026)
- City of Fort Lauderdale, official site (accessed 17 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.